152 related articles for article (PubMed ID: 11007525)
1. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
2. (99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 25084779
[TBL] [Abstract][Full Text] [Related]
3. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
4. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.
Lam AS; Kettle AG; O'Doherty MJ; Coakley AJ; Barrington SF; Blower PJ
Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
[TBL] [Abstract][Full Text] [Related]
6. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake.
Dadachova E; Chapman J
Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202
[TBL] [Abstract][Full Text] [Related]
7. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
Yen TC; King KL; Yang AH; Liu RS; Yeh SH
J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
[TBL] [Abstract][Full Text] [Related]
8. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
9. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
[TBL] [Abstract][Full Text] [Related]
13. Novel tumortropic ester derivatives of 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissue.
Seifert S; Syhre R; Spies H; Johannsen B
Nucl Med Commun; 2003 Nov; 24(11):1175-83. PubMed ID: 14569172
[TBL] [Abstract][Full Text] [Related]
14. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma.
Zissimopoulos A; Zanglis A; Andreopoulos D; Baziotis N
Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022
[TBL] [Abstract][Full Text] [Related]
15. Pentavalent 99mTc DMSA: uptake into a variety of human rhabdomyosarcoma xenografts.
Van der Wall H; Henderson D; Baker R; Murray IP
In Vivo; 1997; 11(1):45-50. PubMed ID: 9067772
[TBL] [Abstract][Full Text] [Related]
16. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications.
Basu S; Nair N; Awasare S; Tiwari BP; Asopa R; Nair C
Br J Radiol; 2004 Apr; 77(916):347-61. PubMed ID: 15107330
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T
Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: an experimental study.
Ercan MT; Gülaldi NC; Unsal IS; Aydin M; Peksoy I; Hasçelik Z
Ann Nucl Med; 1996 Nov; 10(4):419-23. PubMed ID: 9006727
[TBL] [Abstract][Full Text] [Related]
19. Uptake of the 188Re(V)-DMSA complex by cervical carcinoma cells in nude mice: pharmacokinetics and dosimetry.
García-Salinas L; Ferro-Flores G; Arteaga-Murphy C; Pedraza-López M; Hernández-Gutiérrez S; Azorin-Nieto J
Appl Radiat Isot; 2001 Mar; 54(3):413-8. PubMed ID: 11214875
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
Chauhan UP; Babbar A; Kashyap R; Prakash R
Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]